These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 26637895)

  • 21. Survival and treatment of non-small cell lung cancer stage I-II treated surgically or with stereotactic body radiotherapy: patient and tumor-specific factors affect the prognosis.
    Mokhles S; Nuyttens JJ; Maat AP; Birim Ö; Aerts JG; Bogers AJ; Takkenberg JJ
    Ann Surg Oncol; 2015 Jan; 22(1):316-23. PubMed ID: 24962941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reassessment of declines in pulmonary function ≥1 year after stereotactic body radiotherapy.
    Takeda A; Enomoto T; Sanuki N; Handa H; Aoki Y; Oku Y; Kunieda E
    Chest; 2013 Jan; 143(1):130-137. PubMed ID: 22722234
    [TBL] [Abstract][Full Text] [Related]  

  • 23. No clinically significant changes in pulmonary function following stereotactic body radiation therapy for early- stage peripheral non-small cell lung cancer: an analysis of RTOG 0236.
    Stanic S; Paulus R; Timmerman RD; Michalski JM; Barriger RB; Bezjak A; Videtic GM; Bradley J
    Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1092-9. PubMed ID: 24661663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Feasibility report of image guided stereotactic body radiotherapy (IG-SBRT) with tomotherapy for early stage medically inoperable lung cancer using extreme hypofractionation.
    Hodge W; Tomé WA; Jaradat HA; Orton NP; Khuntia D; Traynor A; Weigel T; Mehta MP
    Acta Oncol; 2006; 45(7):890-6. PubMed ID: 16982555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Baseline pulmonary function as a predictor for survival and decline in pulmonary function over time in patients undergoing stereotactic body radiotherapy for the treatment of stage I non-small-cell lung cancer.
    Henderson M; McGarry R; Yiannoutsos C; Fakiris A; Hoopes D; Williams M; Timmerman R
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):404-9. PubMed ID: 18394819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Once-weekly, high-dose stereotactic body radiotherapy for lung cancer: 6-year analysis of 60 early-stage, 42 locally advanced, and 7 metastatic lung cancers.
    Salazar OM; Sandhu TS; Lattin PB; Chang JH; Lee CK; Groshko GA; Lattin CJ
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):707-15. PubMed ID: 18455322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lung stereotactic body radiation therapy: regional nodal failure is not predicted by tumor size.
    Marwaha G; Stephans KL; Woody NM; Reddy CA; Videtic GM
    J Thorac Oncol; 2014 Nov; 9(11):1693-7. PubMed ID: 25185531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elderly patients undergoing SBRT for inoperable early-stage NSCLC achieve similar outcomes to younger patients.
    Mancini BR; Park HS; Harder EM; Rutter CE; Corso CD; Decker RH; Husain ZA
    Lung Cancer; 2016 Jul; 97():22-7. PubMed ID: 27237023
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness analysis of stereotactic body radiotherapy and surgery for medically operable early stage non small cell lung cancer.
    Paix A; Noel G; Falcoz PE; Levy P
    Radiother Oncol; 2018 Sep; 128(3):534-540. PubMed ID: 29706462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stereotactic body radiotherapy for second primary lung cancer and intra-parenchymal lung metastasis in patients previously treated with surgery: evaluation of indications and predictors of decreased respiratory function.
    Ishihara T; Yamada K; Harada A; Yukiue H; Tanahashi M; Niwa H; Matsui T; Yokomura K; Ejima Y; Sasaki R
    Acta Oncol; 2018 Sep; 57(9):1232-1239. PubMed ID: 29722594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proton beam radiotherapy versus three-dimensional conformal stereotactic body radiotherapy in primary peripheral, early-stage non-small-cell lung carcinoma: a comparative dosimetric analysis.
    Macdonald OK; Kruse JJ; Miller JM; Garces YI; Brown PD; Miller RC; Foote RL
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):950-8. PubMed ID: 19801106
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 30 Gy or 34 Gy? Comparing 2 single-fraction SBRT dose schedules for stage I medically inoperable non-small cell lung cancer.
    Videtic GM; Stephans KL; Woody NM; Reddy CA; Zhuang T; Magnelli A; Djemil T
    Int J Radiat Oncol Biol Phys; 2014 Sep; 90(1):203-8. PubMed ID: 25015198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of long-term survival outcomes between stereotactic body radiotherapy and sublobar resection for stage I non-small-cell lung cancer in patients at high risk for lobectomy: A propensity score matching analysis.
    Matsuo Y; Chen F; Hamaji M; Kawaguchi A; Ueki N; Nagata Y; Sonobe M; Morita S; Date H; Hiraoka M
    Eur J Cancer; 2014 Nov; 50(17):2932-8. PubMed ID: 25281527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stereotactic body radiotherapy versus surgery for medically operable Stage I non-small-cell lung cancer: a Markov model-based decision analysis.
    Louie AV; Rodrigues G; Hannouf M; Zaric GS; Palma DA; Cao JQ; Yaremko BP; Malthaner R; Mocanu JD
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):964-73. PubMed ID: 20932688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is pulmonary function damaged by neoadjuvant lung cancer therapy? A comprehensive serial time-trend analysis of pulmonary function after induction radiochemotherapy plus surgery.
    Margaritora S; Cesario A; Cusumano G; Cafarotti S; Corbo GM; Ferri L; Ceppi M; Meacci E; Valente S; D'Angelillo RM; Russo P; Porziella V; Bonassi S; Pasqua F; Sterzi S; Granone P
    J Thorac Cardiovasc Surg; 2010 Jun; 139(6):1457-63. PubMed ID: 20363001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Outcome of three-dimensional conformal radiotherapy for early stage non-small cell lung cancer patients who met or not inclusion criteria for stereotactic-body radiation therapy].
    Kołodziejczyk M; Kępka L; Tyc-Szczepaniak D; Wierzchowski M
    Pneumonol Alergol Pol; 2011; 79(5):326-36. PubMed ID: 21861256
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surgery or stereotactic body radiotherapy for elderly stage I lung cancer? A propensity score matching analysis.
    Miyazaki T; Yamazaki T; Nakamura D; Sato S; Yamasaki N; Tsuchiya T; Matsumoto K; Kamohara R; Hatachi G; Nagayasu T
    Surg Today; 2017 Dec; 47(12):1476-1483. PubMed ID: 28447170
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in pulmonary function tests after neoadjuvant therapy predict postoperative complications.
    Cerfolio RJ; Talati A; Bryant AS
    Ann Thorac Surg; 2009 Sep; 88(3):930-5; discussion 935-6. PubMed ID: 19699923
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stereotactic single-dose radiotherapy (radiosurgery) of early stage nonsmall-cell lung cancer (NSCLC).
    Hof H; Muenter M; Oetzel D; Hoess A; Debus J; Herfarth K
    Cancer; 2007 Jul; 110(1):148-55. PubMed ID: 17516437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stereotactic body radiotherapy for T3 and T4N0M0 non-small cell lung cancer.
    Eriguchi T; Takeda A; Sanuki N; Nishimura S; Takagawa Y; Enomoto T; Saeki N; Yashiro K; Mizuno T; Aoki Y; Oku Y; Yokosuka T; Shigematsu N
    J Radiat Res; 2016 Jun; 57(3):265-72. PubMed ID: 26983978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.